Peripheral T-cell lymphomas are aggressive lymphomas with a rapidly progressive clinical course and sinister prognosis even with the best available treatment modalities. Epstein–Barr virus-positive peripheral T-cell lymphoma is an unusual variant of the disease; it is extremely rare and associated with a fulminant course spanning weeks to months. Treatment protocols are different for this entity because of its rarity.